HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A Moreno-Pelayo Selected Research

Hearing Loss (Hearing Impairment)

11/2006Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C->T mutation in the mitochondrial 12S rRNA gene.
12/2005[Prevalence of the 35delG mutation in the GJB2 gene, del (GJB6-D13S1830) in the GJB6 gene, Q829X in the OTOF gene and A1555G in the mitochondrial 12S rRNA gene in subjects with non-syndromic sensorineural hearing impairment of congenital/childhood onset].
5/2004[Prevalence of the A1555G mutation in the mitochondrial DNA in patients with cochlear or vestibular damage due to aminoglycoside-induced ototoxicity].
8/2003Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss.
12/2002Maternally inherited non-syndromic hearing impairment in a Spanish family with the 7510T>C mutation in the mitochondrial tRNA(Ser(UCN)) gene.
10/2002[Incidence of A1555G mutations in the mitochondrial DNA and 35delG in the GJB2 gene (connexin-26) in families with late onset non-syndromic sensorineural hearing loss from Cantabria].
5/2001A cysteine substitution in the zona pellucida domain of alpha-tectorin results in autosomal dominant, postlingual, progressive, mid frequency hearing loss in a Spanish family.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M A Moreno-Pelayo Research Topics

Disease

7Hearing Loss (Hearing Impairment)
11/2006 - 05/2001
3Ototoxicity
11/2006 - 10/2002
1Sensorineural Hearing Loss
10/2002
1Deafness (Deaf Mutism)
10/2002

Drug/Important Bio-Agent (IBA)

412S ribosomal RNAIBA
11/2006 - 10/2002
3AminoglycosidesIBA
11/2006 - 10/2002
2Anti-Bacterial Agents (Antibiotics)IBA
11/2006 - 10/2002
2Mitochondrial DNA (mtDNA)IBA
05/2004 - 10/2002
1Connexin 30IBA
12/2005
1Connexin 26IBA
12/2005
1Ser Transfer RNAIBA
12/2002
1Cysteine (L-Cysteine)FDA Link
05/2001